Table 1.
Total | Training set | Testing set | P value | ||||
---|---|---|---|---|---|---|---|
2122 | % | 1485 | % | 637 | % | ||
Age | |||||||
≤50 | 269 | 12.7 | 206 | 13.9 | 63 | 9.9 | .001 |
(50,65) | 1181 | 55.7 | 789 | 53.1 | 392 | 61.5 | |
>65 | 672 | 31.7 | 490 | 33.0 | 182 | 28.6 | |
Race | |||||||
White | 1621 | 76.4 | 1143 | 77.0 | 478 | 75.0 | .052 |
Black | 412 | 19.4 | 290 | 19.5 | 122 | 19.2 | |
Other | 89 | 4.2 | 52 | 3.5 | 37 | 5.8 | |
Sex | |||||||
Female | 400 | 18.9 | 283 | 19.1 | 117 | 18.4 | .762 |
Male | 1722 | 81.1 | 1202 | 80.9 | 520 | 81.6 | |
Year of diagnosis | |||||||
≤2010 | 1189 | 56.0 | 841 | 56.6 | 348 | 54.6 | .417 |
>2010 | 933 | 44.0 | 644 | 43.3 | 289 | 45.4 | |
Primary location | |||||||
Supraglottic | 1006 | 47.4 | 701 | 47.2 | 305 | 47.9 | .290 |
Glottic | 810 | 38.2 | 556 | 37.4 | 254 | 39.9 | |
Subglottic | 88 | 4.1 | 65 | 4.4 | 23 | 3.6 | |
Other | 218 | 10.3 | 163 | 11.0 | 55 | 8.6 | |
Histologic type | |||||||
Squamous cell | 2048 | 96.5 | 1432 | 96.4 | 616 | 96.7 | .798 |
Other | 74 | 3.5 | 53 | 3.6 | 21 | 3.3 | |
Grade | |||||||
Well | 155 | 7.3 | 110 | 7.4 | 45 | 7.1 | .113 |
Moderately | 1271 | 59.9 | 887 | 59.7 | 385 | 60.4 | |
Poorly | 677 | 31.9 | 480 | 32.2 | 197 | 30.9 | |
Undifferentiated | 18 | 0.8 | 8 | 0.5 | 10 | 1.6 | |
T classification | |||||||
T1 | 141 | 6.6 | 98 | 6.6 | 43 | 6.8 | .244 |
T2 | 266 | 12.5 | 182 | 12.3 | 84 | 13.2 | |
T3 | 554 | 26.1 | 372 | 25.1 | 182 | 28.6 | |
T4 | 1161 | 54.7 | 833 | 56.1 | 328 | 51.5 | |
ELNs | |||||||
Median (range) | 40 | 0‐97 | 39 | 0‐97 | 41 | 0‐97 | .167 |
MLNR | |||||||
Median (range) | 0.01 | 0‐1 | 0.01 | 0‐1 | 0.01 | 0‐1 | .106 |
Treatment | |||||||
With adjuvant therapy | 610 | 28.7 | 443 | 29.8 | 167 | 26.2 | .094 |
Without adjuvant therapy | 1512 | 71.3 | 1042 | 70.2 | 470 | 73.8 |